Trastuzumab as Intellectual, Medical and Economical Challenge

Publisher： Karger

E-ISSN： 1661-3805|1|2|64-65

ISSN： 1661-3791

Source： Breast Care, Vol.1, Iss.2, 2006-05, pp. : 64-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Trastuzumab in the Treatment of Breast Cancer – New Developments

By  

Breast Care, Vol. 2, Iss. 2, 2007-04 ,pp. : 90-93

Karger

Access to resources Recommend Favorite

Trastuzumab for Early Breast Cancer: Hope or Hype?

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 66-67

Karger

Access to resources Recommend Favorite

Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer

By  

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 252-255

Karger

Access to resources Recommend Favorite

Current Status of Financing and Reimbursement of Trastuzumab (Herceptin®) for Adjuvant and Advanced Therapy of Breast Cancer in Germany

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 86-94

Karger

Access to resources Recommend Favorite

Adjuvanter Einsatz von Trastuzumab (Herceptin®) in der klinischen Praxis außerhalb von klinischen Studien

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 96-101

Karger

Access to resources Recommend Favorite